Join
Live feed
·
INSIDERFilingvia Quantisnow
Nexalin Technology Inc. logo

Chief Medical Officer Owens David bought $950 worth of shares (1,000 units at $0.95), increasing direct ownership by 0.68% to 147,793 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NXL· Nexalin Technology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NXL (Nexalin Technology Inc.) and more on Quantisnow.